Attovia Therapeutics, Inc.
ATTO- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0002058707
In the last 90 days, Attovia Therapeutics, Inc. insiders filed 5 open-market purchases and 1 sale; no institution reported holding it in 13F filings for Q2 2026; no superinvestor holds it.
Open-market trades, last 90 days
Open-market purchases (P) and sales (S) by Attovia Therapeutics, Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.
- Open-market buys
- 5 filings
- 5 insiders, $42.1M in total
- Open-market sells
- 1 filing
- 1 insider, $2.25M in total
- Insiders trading
- 5
- Net value
- +$39.8M
- Purchases minus sales
Insider roster
Directors, officers and 10% owners who have filed a Form 4 for Attovia Therapeutics, Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.
| Name | Title | Last reported holding | Last filing | Filings, past year |
|---|---|---|---|---|
| Walsh Colin | Director | 3,020,632Indirect | Aug 28, 2026 | 1 |
| Goldman Sachs & Co. LLC | Other: Former 10% Owner | 3,020,632Indirect | Aug 28, 2026 | 1 |
| Goldman Sachs Group Inc | Other: Former 10% Owner | 3,020,632Indirect | Aug 28, 2026 | 1 |
| Goldman Sachs Asset Management, L.P. | Other: Former 10% Owner | 3,020,632Indirect | Aug 28, 2026 | 1 |
| Broad Street Principal Investments, L.L.C. | Other: Former 10% Owner | 3,020,632Indirect | Aug 28, 2026 | 1 |
| West Street Life Sciences I, L.P. | Other: Former 10% Owner | 3,020,632Indirect | Aug 28, 2026 | 1 |
| WSLS Emp Offshore Investments, L.P. | Other: Former 10% Owner | 3,020,632Indirect | Aug 28, 2026 | 1 |
| WSLS Offshore Investments, SLP | Other: Former 10% Owner | 3,020,632Indirect | Aug 28, 2026 | 1 |
| WSLS Emp Onshore Investments, L.P. | Other: Former 10% Owner | 3,020,632Indirect | Aug 28, 2026 | 1 |
| Kroin David | 10% Owner | 1,957,138 | Aug 10, 2026 | 1 |
| Deep Track Capital, LP | 10% Owner | 1,957,138 | Aug 10, 2026 | 1 |
| Deep Track Biotechnology Master Fund, Ltd. | 10% Owner | 1,957,138 | Aug 10, 2026 | 1 |
| venBio Global Strategic Fund IV, L.P. | 10% Owner | 4,181,367 | Aug 10, 2026 | 1 |
| Redmile Group, LLC | 10% Owner | 1,182,854Indirect | Aug 7, 2026 | 1 |
| Green Jeremy | 10% Owner | 1,182,854Indirect | Aug 7, 2026 | 1 |
| Redmile Biopharma Investments III, L.P. | 10% Owner | 1,182,854Indirect | Aug 7, 2026 | 1 |
| Sanofi | 10% Owner | 1,082,855Indirect | Aug 7, 2026 | 1 |
| FHMLS XI, L.P. | 10% Owner | 6,154,213 | Aug 6, 2026 | 1 |
| Frazier Life Sciences XI, L.P. | 10% Owner | 6,154,213 | Aug 6, 2026 | 1 |
| FHMLS XI, L.L.C. | 10% Owner | 6,154,213 | Aug 6, 2026 | 1 |
| You Angie | Director | – | Aug 6, 2026 | 1 |
| Gold Mitchell | Director | – | Aug 6, 2026 | 1 |
| Odrowaz Zaneta | Chief Business Officer | – | Aug 6, 2026 | 1 |
| Veiby Petter | Chief Scientific Officer | – | Aug 6, 2026 | 1 |
| Chen Hubert | Chief Medical Officer | – | Aug 6, 2026 | 1 |
| Attovia Therapeutics, Inc. | Chief Financial Officer | – | Aug 6, 2026 | 2 |
Insider trades
Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Aug 28, 2026 (view filing)5:38 PM ET | Aug 5-6 | 23 days | Walsh ColinDirector | PPurchase | +585.0K | $17.58 | +$10.3M | +24.0%3.02M after | Amended2 lotsDuplicate filing |
| Aug 28, 2026 (view filing)5:38 PM ET | Aug 5 | 23 days | Walsh ColinDirector | SSale | −105.8K | $21.28 | −$2.25M | −100.0%0 after | Amended23 lotsDuplicate filing |
| Aug 28, 2026 (view filing)5:38 PM ET | Aug 5 | 23 days | Walsh ColinDirector | PPurchase | +105.8K | $21.25 | +$2.25M | –105.8K after | AmendedDerivative6 lotsDuplicate filing |
| Aug 28, 2026 (view filing)5:38 PM ET | Aug 5-6 | 23 days | Goldman Sachs & Co. LLC and 7 othersOther: Former 10% Owner | PPurchase | +585.0K | $17.58 | +$10.3M | +24.0%3.02M after | Amended2 lots |
| Aug 28, 2026 (view filing)5:38 PM ET | Aug 5 | 23 days | Goldman Sachs & Co. LLC and 7 othersOther: Former 10% Owner | SSale | −105.8K | $21.28 | −$2.25M | −100.0%0 after | Amended23 lots |
| Aug 28, 2026 (view filing)5:38 PM ET | Aug 5 | 23 days | Goldman Sachs & Co. LLC and 7 othersOther: Former 10% Owner | PPurchase | +105.8K | $21.25 | +$2.25M | –105.8K after | AmendedDerivative6 lots |
| Aug 10, 2026 (view filing)4:12 PM ET | Aug 6 | 4 days | venBio Global Strategic Fund IV, L.P.10% Owner | PPurchase | +382.4K | $17.00 | +$6.50M | +10.1%4.18M after | |
| Aug 7, 2026 (view filing)9:47 PM ET | Aug 6 | 1 day | Redmile Group, LLC and 2 others10% Owner | PPurchase | +200.0K | $17.00 | +$3.40M | +25.5%982.9K after | |
| Aug 7, 2026 (view filing)9:47 PM ET | Aug 6 | 1 day | Redmile Group, LLC and 2 others10% Owner | PPurchase | +400.0K | $17.00 | +$6.80M | +51.1%1.18M after | |
| Aug 7, 2026 (view filing)3:45 PM ET | Aug 6 | 1 day | Sanofi10% Owner | PPurchase | +300.0K | $17.00 | +$5.10M | +38.3%1.08M after | |
| Aug 6, 2026 (view filing)5:35 PM ET | Aug 6 | Same day | FHMLS XI, L.P. and 2 others10% Owner | PPurchase | +588.2K | $17.00 | +$10.0M | +10.6%6.15M after |